Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Glia. 2014 Jun 26;62(10):1699–1712. doi: 10.1002/glia.22709

Figure 6.

Figure 6

Expression of IκBαS32/36A inhibits NF-κB in primary VS cultures. Average NF-κB activity in primary VS cultures transduced with with Ad5.empty vector (EV) or Ad5.IκBαS32/36A and treated with proNGF or without proNGF. Activity is expressed as fold change relative to control (Ad5.EV without proNGF). Data are from cultures derived from four separate patients. *p<0.05, **p<0.01 by one way ANOVA followed by Holm Sidak post hoc method.